Leuthold Group LLC Makes New $464,000 Investment in Select Medical Holdings Corporation $SEM

Leuthold Group LLC acquired a new position in Select Medical Holdings Corporation (NYSE:SEM) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 31,264 shares of the health services provider’s stock, valued at approximately $464,000.

A number of other hedge funds have also recently added to or reduced their stakes in SEM. Quantbot Technologies LP acquired a new position in Select Medical in the third quarter worth $27,000. Cornerstone Planning Group LLC boosted its holdings in Select Medical by 6,868.4% in the third quarter. Cornerstone Planning Group LLC now owns 3,972 shares of the health services provider’s stock worth $51,000 after purchasing an additional 3,915 shares during the period. First Horizon Corp bought a new stake in Select Medical in the fourth quarter valued at $52,000. GAMMA Investing LLC lifted its stake in Select Medical by 147.9% in the fourth quarter. GAMMA Investing LLC now owns 4,713 shares of the health services provider’s stock valued at $70,000 after buying an additional 2,812 shares during the last quarter. Finally, Wilmington Savings Fund Society FSB lifted its stake in Select Medical by 20.9% in the third quarter. Wilmington Savings Fund Society FSB now owns 5,784 shares of the health services provider’s stock valued at $74,000 after buying an additional 999 shares during the last quarter. Institutional investors and hedge funds own 89.48% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts have issued reports on the company. Zacks Research upgraded Select Medical from a “strong sell” rating to a “hold” rating in a research note on Monday, May 4th. Weiss Ratings upgraded Select Medical from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Friday, February 20th. Mizuho reiterated a “neutral” rating and issued a $16.50 target price (down from $17.00) on shares of Select Medical in a research note on Tuesday, May 12th. Wall Street Zen cut Select Medical from a “buy” rating to a “hold” rating in a research note on Monday, March 9th. Finally, Royal Bank Of Canada reiterated a “sector perform” rating and issued a $16.50 target price (down from $19.00) on shares of Select Medical in a research note on Tuesday, March 3rd. One research analyst has rated the stock with a Buy rating and six have issued a Hold rating to the stock. Based on data from MarketBeat.com, Select Medical currently has a consensus rating of “Hold” and a consensus price target of $15.50.

Select Medical Price Performance

Shares of NYSE SEM opened at $16.51 on Monday. Select Medical Holdings Corporation has a fifty-two week low of $11.65 and a fifty-two week high of $16.99. The firm’s 50-day simple moving average is $16.35 and its 200 day simple moving average is $15.41. The company has a quick ratio of 1.15, a current ratio of 1.15 and a debt-to-equity ratio of 0.88. The stock has a market cap of $2.05 billion, a P/E ratio of 15.57, a P/E/G ratio of 0.95 and a beta of 1.02.

Select Medical (NYSE:SEM) last issued its quarterly earnings data on Thursday, April 30th. The health services provider reported $0.36 earnings per share for the quarter, missing analysts’ consensus estimates of $0.43 by ($0.07). Select Medical had a net margin of 2.42% and a return on equity of 6.62%. The company had revenue of $1.42 billion for the quarter, compared to the consensus estimate of $1.41 billion. During the same quarter in the prior year, the firm earned $0.44 earnings per share. Select Medical’s revenue for the quarter was up 5.0% compared to the same quarter last year. Select Medical has set its FY 2026 guidance at 1.220-1.320 EPS. Equities analysts expect that Select Medical Holdings Corporation will post 1.26 EPS for the current year.

Select Medical Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, May 28th. Investors of record on Thursday, May 14th will be paid a dividend of $0.0625 per share. This represents a $0.25 dividend on an annualized basis and a dividend yield of 1.5%. The ex-dividend date is Thursday, May 14th. Select Medical’s payout ratio is currently 23.58%.

Select Medical declared that its board has initiated a share repurchase program on Thursday, February 19th that permits the company to buyback $1.00 billion in outstanding shares. This buyback authorization permits the health services provider to repurchase up to 49.5% of its shares through open market purchases. Shares buyback programs are usually an indication that the company’s leadership believes its shares are undervalued.

Select Medical Profile

Select Medical is a leading provider of specialized healthcare services in the United States, operating through two primary business segments: Hospital Division and Outpatient Rehabilitation Division. The Hospital Division offers long-term acute care (LTAC) hospitals and inpatient rehabilitation facilities (IRFs) that serve patients recovering from complex illnesses, trauma or surgery. The Outpatient Rehabilitation Division delivers physical, occupational and speech therapy services through a network of clinic locations and home-based care programs.

Headquartered in Mechanicsburg, Pennsylvania, Select Medical was founded in 1996 and has grown through strategic partnerships, joint ventures and acquisitions.